Harakeh, S. Et Al. 2023. Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis. Journal of King Saud University - Science , vol.35, no.7 .

Harakeh, S., Hassan Saber, S., El-Shitany, N., Ali, S. S., Alamri, T., Al-Rabia, M. W., ... Demeke Teklemariam, A.(2023). Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis. Journal of King Saud University - Science , vol.35, no.7.

Harakeh, Steve Et Al. "Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis," Journal of King Saud University - Science , vol.35, no.7, 2023

Harakeh, Steve Et Al. "Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis." Journal of King Saud University - Science , vol.35, no.7, 2023

Harakeh, S. Et Al. (2023) . "Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis." Journal of King Saud University - Science , vol.35, no.7.

@article{article, author={Steve Harakeh Et Al. }, title={Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis}, journal={Journal of King Saud University - Science}, year=2023}